An individual's experience of pain from medical treatment can be heightened by witnessing other people's responses to the same treatment, with this negative experience subsequently spreading to others, scientists have discovered.
Apr 30, 2024
0
32
Treating stubborn cases of depression in older adults is challenging, and often requires multiple treatments, says UConn Health psychiatrist David Steffens. His review in the New England Journal of Medicine gives doctors ...
Feb 15, 2024
0
27
Researchers from Tel Aviv University compared treatment with a dedicated protocol of hyperbaric oxygen therapy (HBOT) to the pharmacology (drugs) treatment available today for patients suffering from fibromyalgia as a result ...
Mar 23, 2023
0
94
People challenged with chronic back pain have been given hope with a new treatment that focuses on retraining how the back and the brain communicate, a randomized controlled trial run by researchers at UNSW Sydney and Neuroscience ...
Aug 2, 2022
0
1120
Scientists have long noted a connection between opioid use disorder (OUD) and chronic pain, however brain mechanisms linking OUD and chronic pain are poorly understood. This first-of-its-kind study by researchers at The Ohio ...
Jul 11, 2022
0
103
Rethinking what causes pain and how great of a threat it is can provide chronic pain patients with lasting relief and alter brain networks associated with pain processing, according to new University of Colorado Boulder-led ...
Sep 29, 2021
0
87
A new study finds that patients with fibromyalgia have brain networks primed for rapid, global responses to minor changes. This abnormal hypersensitivity, called explosive synchronization (ES), can be seen in other network ...
Jan 12, 2018
0
1858
Scientists at Wake Forest Baptist Medical Center have found new evidence that mindfulness meditation reduces pain more effectively than placebo.
Nov 11, 2015
0
428
Some 30 to 40% of patients do not respond to medications for depression and obsessive-compulsive disorder (OCD), but half of them could be helped by a noninvasive in-office procedure.
May 17, 2024
0
3
The U.S. Drug Enforcement Agency announced in late April 2024 that it plans to ease federal restrictions on cannabis, reclassifying it from a Schedule I drug to the less restricted Schedule III, which includes drugs such ...
May 13, 2024
0
0
